Search

everythinglearnresearchcommunity

for

Search:↓

Some alopecia treatments might help treat COVID-19, but more research is needed.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A male with aromatase deficiency improved bone health with estradiol treatment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Medications for PCOS don't seem to raise heart disease risk.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

PCOS-related infertility is managed with lifestyle changes and medications.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.